1983
DOI: 10.1001/archopht.1983.01040020784025
|View full text |Cite
|
Sign up to set email alerts
|

Herpes Simplex Acyclovir-Resistant Mutant in Experimental Keratouveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

1984
1984
2010
2010

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 28 publications
0
4
0
Order By: Relevance
“…Local toxicity is a major complication with topical use. Experimental studies of aciclovir‐resistant HSV keratouveitis in rabbits have showed vidarabine to be efficacious 29 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Local toxicity is a major complication with topical use. Experimental studies of aciclovir‐resistant HSV keratouveitis in rabbits have showed vidarabine to be efficacious 29 …”
Section: Discussionmentioning
confidence: 99%
“…As an oral formulation it has been used to treat herpes zoster infections 30 . Aciclovir‐resistant HSV strains have been reported to remain sensitive to Brivudin 29 . Hence this may be a possible therapy if required, although there is a lack of clinical trials to support this.…”
Section: Discussionmentioning
confidence: 99%
“…Boisjoly et al. found that vidarabine topically was a possible alternative drug to acyclovir in treating resistant herpes simplex viral keratitis in rabbits 3 …”
mentioning
confidence: 99%
“…Boisjoly et al found that vidarabine topically was a possible alternative drug to acyclovir in treating resistant herpes simplex viral keratitis in rabbits. 3 I also try topical vidarabine ointment in possible drugresistant herpetic keratitis. It is not toxic in the short run, for 2 or 3 weeks five times a day, and is certainly less toxic and less expensive than i.v.…”
mentioning
confidence: 99%